0001161697-22-000469.txt : 20220916 0001161697-22-000469.hdr.sgml : 20220916 20220916170104 ACCESSION NUMBER: 0001161697-22-000469 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220915 FILED AS OF DATE: 20220916 DATE AS OF CHANGE: 20220916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sundaram Preethi CENTRAL INDEX KEY: 0001872422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 221248664 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form_4.xml FORM 4 FOR 09-15-2022 X0306 4 2022-09-15 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001872422 Sundaram Preethi 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 0 1 0 0 Chief Strategy Officer Common stock, par value $0.001 per share 2022-09-15 4 M 0 18214 5.49 A 18214 D Common stock, par value $0.001 per share 2022-09-15 4 S 0 18214 14.49 D 0 D Options to purchase common stock 5.49 2022-09-15 4 M 0 18214 0 A 2022-07-06 2028-07-06 Common Stock 18214 399286 D Shares were sold for personal reasons and not as a result of any disagreement with the Registrant. Dr. Sundaram remains an officer of the Company. /s/ Preethi Sundaram 2022-09-16